3,322 Followers on Owler
Immunocore
Immunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer.
Read more
CEO
Bahija Jallal
IMMUNOCORE TOP COMPETITORS OR ALTERNATIVES
RANK
COMPANY
CEO
CEO RATING
EMPLOYEES
FUNDING
REVENUE
Missing a competitor? Contribute!
Gritstone Oncology is a top competitor of Immunocore. Gritstone Oncology was founded in 2015, and is headquartered in Emeryville, California. Like Immunocore, Gritstone Oncology also competes in the Biotechnology field. Gritstone Oncology generates $3.9M more revenue vs. Immunocore.
Looking for similar companies to Immunocore?
Trending News for Immunocore and Immunocore's Competitors
September 27, 2021
Global Legal Chronicle
Adaptimmune's Collaboration with Genentech
Ropes & Gray represented Adaptimmune in the deal. Adaptimmune signed its strategic collaboration with... See more »
Today 5:16 PM
PR Newswire
FDA Accepts Libtayo (cemiplimab-rwlc) for Priority Review for Advanced Cervical Cancer
TARRYTOWN, N.Y., Sept. 28, 2021 /PRNewswire/ -- European Union regulatory submission planned by end o... See more »
September 27, 2021
MarketScreener
Gilead Sciences : Marks Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization
(marketscreener.com) - Antibody-Drug Conjugate Trodelvy is First Treatment to Show Survival Benefit v... See more »
Immunocore Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$40.9M
Immunocore's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 5B. Over the last two quarters, Immunocore's revenue has decreased by 0%. Specifically, in Q4 2020's revenue was $40.9M; in Q3 2020, it was $40.9M.
Immunocore Acquisitions
No recent acquisitions found related to Immunocore
Immunocore Funding History
Since Immunocore was founded in 2008, it has participated in 6 rounds of funding. In total Immunocore has raised $923.3M. Immunocore's last funding round was on Feb 2021 for a total of $258.3M
Immunocore Investments
No recent investments found related to Immunocore
Immunocore News
August 24, 2021Seeking Alpha
FDA and EMA accepts Immunocore's tebentafusp application in uveal melanoma
August 11, 2021BioSpace
Immunocore Reports Second Quarter 2021 Financial Results and Provides Business Update
Immunocore Holdings plc, a late-stage biotechnology company pioneering the development of a novel cla... See more »
June 4, 2021Markets Insider
Immunocore presents clinical data further characterizing the overall survival benefit of tebentafusp in metastatic uveal melanoma at the 2021 American Society of Clinical Oncology (ASCO) Annual...
PRESS RELEASE Immunocore presentsclinical data further characterizing the overall survival benefit of... See more »
May 27, 2021Markets Insider
Immunocore to present at upcoming investor conferences
PRESS RELEASE Immunocoreto present at upcoming investor conferences(OXFORDSHIRE, England & CONSHOHOCK... See more »
May 18, 2021MarketScreener
Immunocore announces dosing of first patient with ImmTAV bispecific molecule for chronic Hepatitis B
(marketscreener.com) PRESS RELEASE Immunocore announces dosing of first patient with ImmTAV® bispecif... See more »
May 12, 2021BioSpace
Immunocore Reports First Quarter 2021 Financial Results
Immunocore today announced its results for the quarter ended March 31, 2021.... See more »
Immunocore Press Releases
March 25, 2021GlobeNewswire
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results... See more »
June 4, 2018Business Wire
New IMCgp100-102 Data Show Durable Response and Robust Overall Survival Rate in Patients with Metastatic Uveal Melanoma
OXFORD, England & CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Patients with metastatic uveal melanoma (mUM) t... See more »
January 4, 2018EconoTimes
Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors
Immunocore Strengthens its Board with Appointments of
Laura Wade-Gery and Kristine Peterson as Non-E... See more »
June 1, 2017GlobalNewswire
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
December 8, 2015Business Wire
Uveal Melanoma - Pipeline Review, Technologies & Forecasts Report H2 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xssp56/uvea... See more »
Immunocore Videos
Social Media
Immunocore Headquarters
Trending Companies
IN THE NEWS
TreeHouse | Galaxy ME | UnitedHealth Group | EOG Resources | McLane | Xaar | Cousins Furniture Stores | Concho | Discovery | Accenture | Pomerantzlawfirm | Cintas | Kiadis | Westbrooke | Sempra | Gap | Cohbar | Costa | Ayr Strategies Inc | Akamai | Kimberly-Clark | Huawei | Skyworks | GIMEG | Seattle Genetics | PPG | OnePlus | Cummins | Lotus Enterprises | Vestmoldtransgaz | Xilinx | BlackRock | Thermo Fisher | Home Depot | Intel | Advanced Micro Devices | Hologic | Amarin | Verizon | Faber-Castell Cosmetics | Arcane Crypto | General Motors | AutoZone | Fitbit | Suzlon | URBN | Hain Celestial | Mits | molzi | Mohegan Sun
PEOPLE ALSO VIEWED
Pharmascience | Tris Pharma | CytomX | Fisher Clinical Services | Tecan | Novavax | DSM | ARUP | Merck | Ocular Therapeutix | STEMCELL | GVK BIO | ExactCare | Dr.Reddy's | Evogene | Sterigenics | Invoca | Christie's | Sixt | Netwrix | Finbiosoft | Genohm | Epizyme | ImmuneXcite | Lipocine | Dawlance | LovableCommerce | Community Auto Group | Remark Holdings | AWIN
Immunocore Summary
ABOUT
Overview
Immunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer. Immunocore was founded in 2008. Immunocore's headquarters is located in Oxfordshire, England, GB OX14 4RY. It has r...CEO
Immunocore's CEO, Bahija Jallal, currently has an approval rating of 90%. Immunocore's primary competitors are Gritstone Oncology, Adaptimmune & Regeneron.Website
immunocore.comFrequently Asked Questions about Immunocore
When was Immunocore founded?
Immunocore was founded in 2008Who is Immunocore's CEO?
Immunocore's CEO is Bahija JallalHow much revenue does Immunocore generate?
Immunocore generates $40.9M in revenueHow much funding does Immunocore have?
Immunocore has historically raised $923.3M in funding
Where is Immunocore's headquarters?
Immunocore's headquarters is in Oxfordshire England, GBHow many employees does Immunocore have?
Immunocore has 291 employeesWhat sector does Immunocore operate in?
Immunocore is in BiotechnologyWho are Immunocore's competitors?
Immunocore's top competitors are Gritstone Oncology, Adaptimmune, Regeneron